Stock FENNEC PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders Fennec Pharmaceuticals Inc Other OTC

Equities

CA31447P1009

Real-time Estimate Cboe BZX
Other stock markets
 01:15:21 2024-04-29 pm EDT 		5-day change 1st Jan Change
9.185 USD +29.73% Intraday chart for Fennec Pharmaceuticals Inc +3.66% +10.97%
Apr. 23 Fennec Pharmaceuticals Insider Sold Shares Worth $414,472, According to a Recent SEC Filing MT
Apr. 19 Fennec Pharmaceuticals Insider Sold Shares Worth $433,996, According to a Recent SEC Filing MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Fennec Pharmaceuticals Insider Sold Shares Worth $414,472, According to a Recent SEC Filing
MT
Fennec Pharmaceuticals Insider Sold Shares Worth $433,996, According to a Recent SEC Filing
MT
Fennec Pharmaceuticals Insider Sold Shares Worth $457,182, According to a Recent SEC Filing
MT
Fennec Pharmaceuticals Insider Sold Shares Worth $958,669, According to a Recent SEC Filing
MT
Fennec Pharmaceuticals Insider Sold Shares Worth $437,451, According to a Recent SEC Filing
MT
Fennec Pharmaceuticals Reports Q2 2023 Net Loss of US$5.4 Million; Appoints Adrian Haigh as Chief Operating Officer
MT
Fennec Pharmaceuticals Inc. Announces the Appointment of Adrian Haigh as Chief Operating Officer
CI
Insider Sell: Fennec Pharmaceuticals
MT
Insider Sell: Fennec Pharmaceuticals
MT
Fennec Pharmaceuticals Chief Commercial Officer Resigns
MT
Shubh Goel to Depart Fennec Pharmaceuticals Inc. as Chief Commercial Officer in Late February 2022
CI
Fennec Pharmaceuticals Inc Announces Launch of European Named Patient Programme for Sodium Thiosulfate for Pediatric Patients with Standard Risk Hepatoblastoma
CI
Fennec Pharmaceuticals Inc. Appoints Marco Brughera to the Board of Directors
CI
Fennec Pharmaceuticals Inc. Appoints Khalid Islam as Chairman of the Board of Directors
CI
Adherex Technologies Inc. has Changed its Name to Fennec Pharmaceuticals Inc
CI
Adherex Technologies Inc. Announces the Appointment of Khalid Islam and Adrian Haigh to its Board of Directors
CI
Adherex Technologies Inc. Announces Executive Changes
CI
Thomas Spector Resigns as Chief Scientific Officer of Adherex Technologies Inc
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FENC Stock
  4. Stock
  5. News Fennec Pharmaceuticals Inc
  6. Insiders